Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study to Assess the Feasibility, Efficacy and Safety of Extended-release Injectable Buprenorphine for the Treatment of Opioid Use Disorder Among Individuals at High Risk of Overdose

NCT04815590 is registered in ClinicalTrials.gov with BC Centre on Substance Use as lead sponsor.

NCT NCT04815590
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04815590 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study to Assess the Feasibility, Efficacy and Safety of Extended-release Injectable Buprenorphine for the Treatment of Opioid Use Disorder Among Individuals at High Risk of Overdose
Lead sponsor
BC Centre on Substance Use
Phase
Observational
Overall status
Unknown status
Start date
October 17, 2022
Completion date
October 17, 2023
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid overdose, opioid-use disorder